Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Sana Health

Request full access

Manufactures a smart sleep mask to aide insomniacs

Louisville, United StatesFounded 2015Health Tech & Medtech

About Sana Health

Sana Health operates in the medical technology sector, focusing on non-pharmaceutical solutions for chronic pain, mental well-being, and sleep issues. The company's genesis is deeply rooted in the personal story of its founder and CEO, Richard Hanbury. In 1992, at the age of 19, Hanbury survived a jeep crash in Yemen that resulted in a severe spinal cord injury and excruciating, life-threatening nerve pain. Faced with a grim prognosis, he embarked on a decades-long journey to find a solution for his own suffering, which led to the creation of the Sana device. This personal mission to overcome his pain forms the core of the company's vision. Hanbury's background includes an MBA from the Wharton School and prior experience at McKinsey.

The business is centered around its primary product, the Sana device, a neuromodulation platform. This non-invasive wearable resembles a mask and uses coordinated pulses of light and sound to guide the user's brain into a state of deep relaxation, mimicking the effects of long-term meditation. A key feature is a heart rate variability (HRV) sensor that creates a biofeedback loop, personalizing the audiovisual patterns to deepen the user's state of relaxation. This technology is designed to help users accelerate physical recovery, improve mental well-being, and achieve more restful sleep. The company targets individuals suffering from conditions like neuropathic pain, fibromyalgia, and PTSD.

Sana Health's business model revolves around the development and future sale of this medical device, contingent on regulatory clearance. The company is actively engaged in clinical trials to validate its technology's efficacy for various conditions. Significant milestones include receiving a Breakthrough Device Designation from the FDA and securing a $3.4 million grant from the U.S. Department of Defense to conduct a pivotal study on PTSD. Sana Health has submitted data from its neuropathic pain study to the FDA for market approval and anticipates a decision between late 2024 and mid-2025. The company has pursued a strategy of securing grants and raising capital through funding rounds to finance its extensive research and development and navigate the FDA approval process.

Source: Dealroom company data

Sana Health in the Louisville ecosystem

Live from Dealroom

The Sana Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed8 investors entered at this stage

Series A1 investor entered at this stage

  • Noetic Fund
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States80%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Sana Health on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Sana Health on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.